TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 77 filers reported holding TREACE MED CONCEPTS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,125,185 | +39569.8% | 122,173 | -60.9% | 0.00% | -60.0% |
| Q1 2023 | $7,878 | +609.7% | 312,751 | +548.0% | 0.01% | +400.0% |
| Q4 2022 | $1,110 | -100.0% | 48,261 | -84.2% | 0.00% | -66.7% |
| Q2 2022 | $4,393,000 | -62.7% | 306,376 | -50.8% | 0.00% | -50.0% |
| Q1 2022 | $11,768,000 | +202.4% | 622,293 | +198.0% | 0.01% | +200.0% |
| Q4 2021 | $3,892,000 | +175.2% | 208,824 | +297.2% | 0.00% | +100.0% |
| Q3 2021 | $1,414,000 | +362.1% | 52,575 | +437.2% | 0.00% | – |
| Q2 2021 | $306,000 | – | 9,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXT CENTURY GROWTH INVESTORS LLC | 1,595,387 | $36,677,947 | 4.40% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 945,973 | $21,747,919 | 1.35% |
| EMERALD ADVISERS, LLC | 1,188,246 | $27,317,776 | 1.32% |
| Perceptive Advisors | 1,946,403 | $44,747,805 | 1.26% |
| Novo Holdings A/S | 637,317 | $14,651,918 | 0.92% |
| SECTORAL ASSET MANAGEMENT INC | 179,924 | $4,136,453 | 0.80% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 493,213 | $11,338,967 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 139,960 | $3,218 | 0.50% |
| TimesSquare Capital Management, LLC | 976,000 | $22,438 | 0.32% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 770,817 | $17,721,083 | 0.26% |